News

Applied Clinical Trials Online4h
Johnson & Johnson's TAR-200 for Bladder Cancer Shows High Rates of Disease-Free Survival, Bladder Preservation
Early findings from Johnson & Johnson’s Phase IIb SunRISe-1 trial show the promise of TAR-200 in patients with Bacillus ...
Applied Clinical Trials Online22h
Pivotal Phase III Trial Data Show Pfizer’s Sasanlimab with BCG Significantly Improves Event-Free Survival in Bladder Cancer
In the pivotal CREST clinical trial, sasanlimab in combination with Bacillus Calmette-Guérin met the primary endpoint of ...